Table 2 Experimental design
Experimental Groups | Time-Points (Number of Animals per sex M/F) | Key to Abbreviated Terms for Experimental Groups | Conditions Describing Experimental Group | |||
|---|---|---|---|---|---|---|
Day 45 | Day 90 | Day 135 | Day 180 | |||
Control* | (5/5) | (5/5) | (5/5) | (5/5) | C = Control | No-MAP infection; No- probiotics in diet |
L-MAP* | (5/5) | (5/5) | (5/5) | (5/5) | L-MAP = Viable MAP | MAP infection; No probiotics in diet |
K-MAP | (5/5) | (5/5) | (5/5) | (5/5) | K-MAP = Non-viable MAP | Non-viable MAP antigen; No probiotics in diet |
L-NP-51* | (5/5) | (5/5) | (5/5) | (5/5) | L-NP-51 = Viable Probiotics | No-MAP infection; probiotics in diet |
L-MAP + L-NP-51* | (5/5) | (5/5) | (5/5) | (5/5) | L-MAP + L-NP-51= Viable MAP & Probiotics | MAP infection; probiotics in diet |
K-MAP + L-NP-51* | (5/5) | (5/5) | (5/5) | (5/5) | K-MAP + L-NP-51 = Non- Viable MAP & Viable Probiotics | Non-viable MAP antigen; probiotics in diet |
K-NP-51 | (5/5) | (5/5) | (5/5) | (5/5) | K-NP-51= Non-viable Probiotics | Non-viable probiotics in diet |
Maltodextrin | (5/5) | (5/5) | (5/5) | (5/5) | MD= Maltodextrin | Filler material in diet |
K-MAP + K-NP-51 | (5/5) | (5/5) | (5/5) | (5/5) | K-MAP + K-NP-51 = Non- viable MAP & Non-viable NP-51 | Non-viable MAP antigen; non-viable probiotics in diet |
L-MAP + K-NP-51 | (5/5) | (5/5) | (5/5) | (5/5) | L-MAP + K-NP-51 | Viable- MAP antigen; and non- viable probiotics in diet |
Total Animals Per Time Point 100 | ||||||